Newark, July 04, 2022 (GLOBE NEWSWIRE) — As per the report published by The Brainy Insights, the global hemostasis analyzers market is expected to grow from USD 3.86 billion in 2020 to USD 7.50 billion by 2028, at a CAGR of 8.56% during the forecast period 2021-2028.
Technological advancement in the hemostasis analyzers, positively influencing the growth of the market. Many systems have been launched in the market such as dual- and four-channel systems that can be simultaneously used for testing of PT, APTT, ACT, and fibrinogen testing. In addition to this, technological advances in point-of-care procedures, along with quality assurance and home testing services, are likely to positively influence the growth of the market over the forecast period.
Request a Sample Copy of the Research Report: https://www.thebrainyinsights.com/enquiry/sample-request/12505
A hemostasis analyzers are laboratory equipments which help medical practitioners for treating patients with blood clotting and bleeding disorder. These analyzers measure the clotting mechanisms of hemostasis deficiencies related to thrombocytopenia, thromboembolytic disease, impaired liver function, hemophilia, and other conditions. A hemostasis analyzer (or coagulation analyzer) provides either mechanical or optical clot detection –and some hemostasis analyzers can accomplish both. While most hemostasis analyzers are heading toward ease of use, accuracy, and timely results, focus has shifted to better…
